Genprex GNPX Stock
0.29 USD
{{ price }}
2.879221%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
7.08M USD
LOW - HIGH [24H]
0.26
-
0.32 USD
VOLUME [24H]
19.57M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-5.34 USD
Genprex Price Chart
Genprex GNPX Financial and Trading Overview
| Genprex stock price | 0.29 USD |
| Previous Close | 0.85 USD |
| Open | 0.84 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 800 |
| Day's Range | 0.84 - 0.88 USD |
| 52 Week Range | 0.72 - 2.67 USD |
| Volume | 166.44K USD |
| Avg. Volume | 444.3K USD |
| Market Cap | 44.19M USD |
| Beta (5Y Monthly) | -0.322887 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.5 USD |
GNPX Valuation Measures
| Enterprise Value | 26.11M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0736585 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.3882022 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.94 |
Trading Information
Genprex Stock Price History
| Beta (5Y Monthly) | -0.322887 |
| 52-Week Change | -35.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.67 USD |
| 52 Week Low | 0.72 USD |
| 50-Day Moving Average | 0.85 USD |
| 200-Day Moving Average | 1.21 USD |
GNPX Share Statistics
| Avg. Volume (3 month) | 444.3K USD |
| Avg. Daily Volume (10-Days) | 354.49K USD |
| Shares Outstanding | 51.98M |
| Float | 51.18M |
| Short Ratio | 8.32 |
| % Held by Insiders | 4.50% |
| % Held by Institutions | 7.79% |
| Shares Short | 2.01M |
| Short % of Float | 3.91% |
| Short % of Shares Outstanding | 3.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -55.37% |
| Return on Equity (ttm) | -99.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27768408 USD |
| Net Income Avi to Common (ttm) | -27633578 USD |
| Diluted EPS (ttm) | -0.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.08M USD |
| Total Cash Per Share (mrq) | 0.35 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.124 |
| Book Value Per Share (mrq) | 0.356 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20639704 USD |
| Levered Free Cash Flow (ttm) | -10521287 USD |
Profile of Genprex
| Country | United States |
| State | TX |
| City | Austin |
| Address | 3300 Bee Cave Road |
| ZIP | 78746 |
| Phone | (877) 774-4679 |
| Website | https://www.genprex.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Q&A For Genprex Stock
What is a current GNPX stock price?
Genprex GNPX stock price today per share is 0.29 USD.
How to purchase Genprex stock?
You can buy GNPX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genprex?
The stock symbol or ticker of Genprex is GNPX.
Which industry does the Genprex company belong to?
The Genprex industry is Biotechnology.
How many shares does Genprex have in circulation?
The max supply of Genprex shares is 24.15M.
What is Genprex Price to Earnings Ratio (PE Ratio)?
Genprex PE Ratio is now.
What was Genprex earnings per share over the trailing 12 months (TTM)?
Genprex EPS is -5.34 USD over the trailing 12 months.
Which sector does the Genprex company belong to?
The Genprex sector is Healthcare.
Genprex GNPX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Capital Market Composite RCMP | 102.11 USD — |
-0.04
|
— — | 100.72 USD — | 103.65 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}